MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer
2017 · Journal of Clinical Oncology · 1,679 citations
https://doi.org/10.1200/jco.2017.75.6155
O
Olivier Trédan
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
555
Papers
17.3K
Citations
55
h-index
155
i10-index
Olivier Trédan is an academic researcher from Université Claude Bernard Lyon 1. The author has contributed to research in topics: Cancer Treatment and Pharmacology & Breast Cancer Treatment Studies & Cancer Genomics and Diagnostics. The author has an h-index of 55, co-authored 472 publications.
ORCID: 0000-0001-5881-9383Papers by this author
worksMolecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial
2015 · The Lancet Oncology · 1,089 citations
https://doi.org/10.1016/s1470-2045(15)00188-6
Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
2021 · Annals of Oncology · 702 citations
https://doi.org/10.1016/j.annonc.2021.05.801
Overall survival with sacituzumab govitecan in hormone receptor-positive and human epidermal growth factor receptor 2-negative metastatic breast cancer (TROPiCS-02): a randomised, open-label, multicentre, phase 3 trial
2023 · The Lancet · 380 citations
https://doi.org/10.1016/s0140-6736(23)01245-x
Sacituzumab Govitecan in Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer
2022 · Journal of Clinical Oncology · 282 citations
https://doi.org/10.1200/jco.22.01002
A phase II trial of abiraterone acetate plus prednisone in patients with triple-negative androgen receptor positive locally advanced or metastatic breast cancer (UCBG 12-1)
2016 · Annals of Oncology · 278 citations
https://doi.org/10.1093/annonc/mdw067
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat